Group hopes to eliminate confusion about mammography screening process, risks involved
Many women remained confused regarding the actual risk of call back, supplemental imaging and biopsy associated with mammography. The American College of Radiology created a new infographic to help patients better understand the process.
For more information: www.acr.org
Aug. 3, 2026 — QT Imaging Holdings, is advancing the direct U.S. commercial strategy for its Breast Acoustic CT Scanner ...
August 04, 2026 
Aug. 3, 2026 — GE HealthCare has launched Invenia ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue, a ...
August 03, 2026 
July 30, 2026 — DeepHealth, Inc. has received FDA 510(k) clearance for DeepHealth Breast Ultrasound1, an AI-powered ...
July 31, 2026 
July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...
July 27, 2026 
July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...
July 07, 2026 
July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...
July 02, 2026 
June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...
June 30, 2026 
June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...
June 24, 2026 
June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...
June 02, 2026 
May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...
May 22, 2026 